Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.
The detailed records of NSC 269719 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269719; 2) Community: the network communities that were significantly associated with the response to NSC 269719; 3) Molecule: the relationships between components within communities and NSC 269719; 4) MDR: the compounds that were significantly associated with the NSC 269719.
| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 758535 | Null | 0.0457230037898008 | 0.28169814 |
| NSC 760016 | (E)-3-(3,5-dimethoxyphenyl)-1-(4-(quinazolin-4-ylamino)phenyl)prop-2-en-1-one | 0.0457230037898008 | 0.14645589 |
| NSC 762458 | Null | 0.0457230037898008 | 0.21303592 |
| NSC 269720 | Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- | 1.18082646562029e-006 | 0.79142983 |